Showing results (2011-2020 of 2,777) with videos related to

Sort By:
Pageof 278
Clinical and Experimental Nephrology|February 10, 2024
Upward-directed exit-site of the swan-neck catheter and "Easy-to-disinfect the backside area of exit-site" may prevent PD complicationsKyohei Ogawa, Masato Ikeda, Izumi Shirai, et al.
Clinical and Experimental Nephrology|February 10, 2024
Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake leesToshiaki Tokumaru, Tadashi Toyama, Yusuke Nakade, et al.
Clinical and Experimental Nephrology|April 6, 2024
Cigarette smoking and progression of kidney dysfunction: a longitudinal cohort studyAyako Matsumoto, Yasuyuki Nagasawa, Ryouhei Yamamoto, et al.
Clinical and Experimental Nephrology|March 13, 2024
Genotype-phenotype correlations in children with Gitelman syndromeMyung Hyun Cho, Peong Gang Park, Ji Hyun Kim, et al.
Clinical and Experimental Nephrology|July 6, 2024
Mind the gap in kidney care: translating what we know into what we doValerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, et al.
Clinical and Experimental Nephrology|July 2, 2024
Effect of tonsillectomy combined with steroid pulse therapy upon IgA nephropathy depending on proteinuria status at diagnosis: a nationwide multicenter cohort study in JapanHiroyuki Komatsu, Shouichi Fujimoto, Yuji Sato, et al.
Clinical and Experimental Nephrology|July 6, 2024
Favorable changes in the eGFR slope after dapagliflozin treatment and its association with the initial dipRina Kawano, Tatsuya Haze, Akira Fujiwara, et al.
Clinical and Experimental Nephrology|July 6, 2024
Guidelines for clinical evaluation of chronic kidney disease in early stages : AMED research on regulatory science of pharmaceuticals and medical devicesYuka Sugawara, Eiichiro Kanda, Takayuki Hamano, et al.
Clinical and Experimental Nephrology|March 26, 2024
Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studiesMasaomi Nangaku, Kiichiro Ueta, Kenichi Nishimura, et al.
Clinical and Experimental Nephrology|April 13, 2024
Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 studyHideki Ishida, Norihiko Goto, Ryoichi Imamura, et al.
Pageof 278